Hospitalization for Myocardial Infarction with Ticagrelor or Clopidogrel in Patients with Acute Coronary Syndrome: An On-Treatment Comparative Effectiveness Analysis.

Olufade, Tope; Atreja, Nipun; Bhalla, Narinder; Venditto, John; Bhandary, Durgesh; Chafekar, Kaushik; Cobden, David; Khan, Naeem D

Olufade, Tope; Atreja, Nipun; Bhalla, Narinder; Venditto, John; Bhandary, Durgesh; Chafekar, Kaushik; Cobden, David; Khan, Naeem D.

Afiliação

Olufade T; AstraZeneca, Wilmington, DE, USA. tope.olufade@astrazeneca.com.
Atreja N; AstraZeneca, Wilmington, DE, USA.
Bhalla N; AstraZeneca, Wilmington, DE, USA.
Venditto J; AstraZeneca, Wilmington, DE, USA.
Bhandary D; AstraZeneca, Wilmington, DE, USA.
Chafekar K; ZS Associates India Pvt. Ltd., Pune, Maharashtra, India.
Cobden D; AstraZeneca, Wilmington, DE, USA.
Khan ND; AstraZeneca, Wilmington, DE, USA.

Cardiol Ther ; 10(2): 515-529, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34389941

Palavras-chave

Acute coronary syndromes; Antiplatelet therapy; Clopidogrel; Comparative effectiveness; Dual antiplatelet therapy; Myocardial infarction; Outcomes; Ticagrelor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cardiol Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google